Myriad Genetics, Inc.
Myriad Genetics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,447 | -3.5 | 1.28 | 0.69 | 388.55 |
| Oct 2026 | 20,395 | -3.5 | 1.31 | 0.69 | 394.03 |
| Oct 2026 | 20,247 | -3.6 | 1.37 | 0.69 | 413.08 |
| Oct 2026 | 20,497 | -3.4 | 1.25 | 0.69 | 376.97 |
| Oct 2026 | 20,325 | -3.6 | 1.32 | 0.69 | 399.18 |
| Oct 2026 | 19,332 | -4.7 | 1.74 | 0.69 | 525.28 |
| Oct 2026 | 19,310 | -4.7 | 1.75 | 0.69 | 526.82 |
| Oct 2026 | 19,168 | -4.9 | 1.81 | 0.69 | 543.69 |
Myriad Genetics, Inc. Quarterly Results
Quarterly data isn't available for this company right now.
Myriad Genetics, Inc. Revenue & Profit
Annual financial data isn't available for this company right now.
Myriad Genetics, Inc. Balance Sheet
Balance sheet data isn't available for this company right now.
Owes vs Owns
Myriad Genetics, Inc. owed $0.52 for every $1 it owned in Jun 2026, up from $0.26 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.52× | 0.48× | 0.32× | 0.32× | 0.26× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Myriad Genetics, Inc. Cash Flow
Cash flow data isn't available for this company right now.